Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nalbuphine Adjuvant in Superficial Cervical Plexus Block for Thyroid Surgery
NCT06633068Phase 2Recruiting
- Sponsor
- Cairo University
- Start
- Jul 2024
- Primary completion
- Apr 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of nalbuphine in postoperative pain (2 arms), sponsored by Cairo University. Primary endpoint: Time to first rescue analgesia at 24 hours. Started Jul 2024; status: recruiting.
02
Drugs
nalbuphine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06633068.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06633068.